Related Experiment Videos

PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development

H Huang1, C J Potter, W Tao

  • 1Howard Hughes Medical Institute and Department of Genetics, Yale University School of Medicine, Boyer Center for Molecular Medicine, New Haven, CT 06536-0812, USA.

Development (Cambridge, England)
|November 11, 1999
PubMed

Insights

The tumor suppressor gene PTEN is crucial for cell size and survival. Inactivation or overexpression of PTEN impacts cell cycle and promotes cell death, particularly in the eye during development.

Area of Science:

  • Genetics and Molecular Biology
  • Developmental Biology
  • Cancer Research

Background:

  • Mutations in the PTEN (Phosphatase and tensin homolog) tumor suppressor gene are linked to numerous human cancers and genetic disorders.
  • PTEN-deficient mice exhibit embryonic lethality, and their fibroblasts show reduced apoptosis.
  • PTEN's role in mammalian cells influences proliferation, cell death, and migration.

Purpose of the Study:

  • To investigate the function of the Drosophila PTEN gene in cellular processes.
  • To determine the effects of PTEN gene inactivation and overexpression on cell size, cell cycle, and cell death.
  • To explore PTEN's interaction with the insulin signaling pathway.

Main Methods:

  • Gene characterization of Drosophila PTEN.
  • Analysis of cell size, cell cycle progression, and cell death in response to PTEN manipulation.
  • Investigating PTEN's role in the insulin signaling pathway using Drosophila models.

Main Results:

  • Both PTEN gene inactivation and overexpression alter cell size in Drosophila.
  • Overexpression of PTEN inhibits cell cycle progression at early mitosis and induces context-dependent cell death during eye development.
  • Drosophila and human PTEN antagonize insulin receptor signaling, indicating PTEN's conserved role in this pathway.

Conclusions:

  • Drosophila PTEN plays a significant role in regulating cell size, cell cycle, and cell death.
  • PTEN functions as a negative regulator within the insulin signaling pathway.
  • These findings suggest PTEN as a potential therapeutic target for conditions involving aberrant insulin signaling.

Related Concept Videos